Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +25.00%
#4 Velvet Velvet +21.00%
#5 Fabric Protocol Fabric Protocol +18.10%
#6 Bedrock Bedrock +16.64%
#7 Nillion Nillion +14.65%
#8 Perle Perle +14.35%
#9 Nockchain Nockchain +14.08%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Sirona Biochem Corp. Sirona Biochem Corp.

Sirona Biochem Corp.

SRBCF
株式のランク #37537
Sirona Biochem Corp. operates as a biotechnology company dedicated to... Sirona Biochem Corp. operates as a biotechnology company dedicated to uncovering and commercializing active ingredients for both cosmetic and pharmaceutical uses, with a commercial presence in Canada and France. Key initiatives include the development of a cosmetic skin brightener and a pharmaceutical solution for diabetes. Beyond these, the company is engaged in several other projects, such as building a library of anti-aging and cell-protective compounds, creating a novel anti-wrinkle agent, and pursuing an antiviral research program. A notable collaboration exists with the International Centre for Genetic Engineering and Biotechnology (ICGEB) for the joint development of an antiviral compound library. Established in 2006, the business, originally named High Rider Capital Inc., rebranded as Sirona Biochem Corp. in May 2009 and maintains its headquarters in Vancouver, Canada.
株価
$0.0051
最終同期: 2026-08-13
時価総額
$1.63M
変化（1日）
0.00%
変化（1年）
-60.31%
国
CA
取引 Sirona Biochem Corp. (SRBCF)

カテゴリー

Healthcare
Sirona Biochem Corp.（SRBCF）のP/B比率
2026 時点のP/B比率 TTM: 0
Sirona Biochem Corp. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Sirona Biochem Corp. の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE